Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



Minerva Business Angels partners with Aston University and University of Birmingham Enterprise to launch new angel investor network for Birmingham

27 February 2019: Aston University and University of Birmingham Enterprise have teamed up with Minerva, one of the UK’s largest traditional angel investor networks, to expand the funding opportunities available to start-up businesses in the West Midlands by launching a network of ‘business angels with insight’ for Birmingham.

Read the rest of entry »

Absolute Antibody Develops Custom Purification Systems to Enable High-Throughput Recombinant Antibody Production

Oxford, UK, February 20, 2019. Absolute Antibody Ltd., an industry-leading manufacturer of recombinant antibodies, has developed custom protein purification systems to significantly increase its antibody production throughput.

Read the rest of entry »

OBN Launches New Purchasing Platform to Provide E-Commerce Solution for its Members

Abingdon, UK; 19th February 2019 - OBN, the Membership organisation supporting the UK’s innovative life sciences companies, is pleased to announce today the launch of its new online Purchasing Platform.  The aim of the new Purchasing Platform, which can be accessed by OBN’s Full Members, Sponsors and Supporters, is to enable users to have a better overview and control of spend and save time and money.

Read the rest of entry »

Innovate UK have released their Smart Grants competition which has £20 million available to all industry sectors

Good news! It’s finally here and has been rebranded as Smart Grants. If you’ve been working within the R&D funding world for as long as we have, you will know that a couple of years ago, ‘Smart’ was the name of the Open, so the name may induce a slight feeling of déjà vu!

Read the rest of entry »

CRISPR/Cas9 Knockout Cell Lines and Lysates

AMSBIO has established a comprehensive portfolio of knock-out cell lines and lysates generated with CRISPR/Cas9 technology.

Using CRISPR/Cas9 gene editing technology for the generation of knock-out cell lines and cell lysates ensures the development of useful tools to validate antibody specificity and elucidate gene function. Knock-out cell lines and cell lysates are widely agreed to be the best negative controls to quickly and confidently prove an antibody’s specificity for a target of interest and ensure reproducibility.

Read the rest of entry »

PRESS RELEASE First production and administration of Axumin® (fluciclovine (18F)) in Italy.

Oxford, UK – February 12, 2019 – Blue Earth Diagnostics, a leading molecular imaging diagnostics company, today announced that the first commercial production of Axumin® (fluciclovine (18F)) in Italy occurred recently, with the first Italian patients being dosed.

Read the rest of entry »

Super-Fast-Acting Prandial Insulin Product Receives £0.5M Innovate UK Boost

Arecor Ltd, the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, is pleased to announce that the Company has been awarded a £0.5 million grant from Innovate UK, the UK’s innovation agency, to advance the Company's proprietary super-fast-acting prandial insulin product, AT270.

Read the rest of entry »

Metal Coated Substrates for Characterizing Self-Assembled Monolayers 

AMSBIO is a leading supplier of gold, silver and platinum coated substrates for nanotechnology researchers looking to use these surfaces to characterize self-assembled monolayers using atomic force microscopy (AFM), or scanning tunneling microscopy (STM).

Read the rest of entry »

Grey Wolf Therapeutics completes £10 million ($14 million) series A financing.

Grey Wolf Therapeutics completes £10 million ($14 million) series A financing with Andera Partners and Canaan to fund development of immuno-oncology therapies to increase tumour visibility

Read the rest of entry »

BioCity appointed to run life science business accelerator

BioCity, the UK’s largest life science incubator has been appointed by Newcastle City Council to run a life science accelerator and business support programme from The Biosphere, which is based on Newcastle Helix. 

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.